SCHEMBL355186

SCHEMBL355186

Cc1ccc(-n2c3ccccc3c3cc(B(O)O)ccc32)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
ATM Q13315 1/20 0.44
CA2 P00918 2/20 0.43
LPL P06858 1/20 0.43
LIPG Q9Y5X9 1/20 0.43
MAPT P10636 3/20 0.42
LMNA P02545 2/20 0.42
HTT P42858 2/20 0.42
POLB P06746 2/20 0.41
GAA P10253 2/20 0.39
AKR1C4 P17516 1/20 0.37
AKR1C3 P42330 1/20 0.37
AKR1C2 P52895 1/20 0.37
AKR1C1 Q04828 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.36
GFER P55789 1/20 0.36
LIG1 P18858 1/20 0.35
BCHE P06276 1/20 0.35
ACHE P22303 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30296694 1.00 KDM4E (0.44) KDM4EL3MBTL1ATMCA2LPL
SCHEMBL18525478 0.92 KDM4E (0.52) KDM4EL3MBTL1ATMCA2MAPT
SCHEMBL355909 0.92 CA2 (0.50) KDM4EL3MBTL1CA2LPLLIPG
SCHEMBL26218478 0.92 KDM4E (0.40) KDM4EL3MBTL1ATMCA2LPL
SCHEMBL13431620 0.91 KDM4E (0.44) KDM4EL3MBTL1ATMCA2LPL
SCHEMBL17885353 0.91 KDM4E (0.50) KDM4EL3MBTL1ATMCA2LMNA
SCHEMBL260470 0.88 KDM4E (0.60) KDM4EL3MBTL1ATMCA2MAPT
SCHEMBL29407532 0.88 KDM4E (0.60) KDM4EL3MBTL1ATMCA2MAPT
SCHEMBL29943786 0.88 KDM4E (0.60) KDM4EL3MBTL1ATMCA2MAPT
SCHEMBL15762939 0.87 KDM4E (0.55) KDM4EL3MBTL1ATMCA2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4186898-A1 COMPOSITION FOR ORGANIC ELECTRONIC COMPOUNDS Merck Patent GmbH (DE) 2023-05-31 EP disclosed
US-20230150987-A1 COMPOSITION FOR ORGANIC ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2023-05-18 US disclosed
US-20230150987-A1 COMPOSITION FOR ORGANIC ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2023-05-18 US disclosed
WO-2020241730-A1 ARYLAMINE COMPOUND AND USE THEREOF 日産化学株式会社 2020-12-03 WO disclosed
US-20200231578-A1 COMPOSITION FOR ORGANIC ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2020-07-23 US disclosed
EP-2477979-B1 COMPOUNDS FOR ORGANIC LIGHT EMITTING DIODE EMISSIVE LAYERS NITTO DENKO CORP (JP) 2016-10-26 EP disclosed
EP-2477979-B1 COMPOUNDS FOR ORGANIC LIGHT EMITTING DIODE EMISSIVE LAYERS NITTO DENKO CORP (JP) 2016-10-26 EP disclosed
US-9472768-B2 Material for an organic optoelectronic device, organic light emitting diode including the same, and display device including the organic light emitting diode CHEIL INDUSTRIES, INC. (KR) 2016-10-18 US disclosed
US-9472768-B2 Material for an organic optoelectronic device, organic light emitting diode including the same, and display device including the organic light emitting diode CHEIL INDUSTRIES, INC. (KR) 2016-10-18 US disclosed
US-9425402-B2 Polymerizable monomer, and material for organic device, hole injection/transport material, material for organic electroluminescence element and organic electroluminescent element each comprising polymer (polymeric compound) of the polymerizable monomer IDEMITSU KOSAN CO., LTD. (JP) 2016-08-23 US disclosed
WO-2012012295-A1 PHOTOTHERAPY DEVICES AND METHODS COMPRISING SUBSTITUTED CARBAZOLE COMPOUNDS NITTO DENKO CORPORATION (JP) 2012-01-26 WO disclosed
US-20120016449-A1 PHOTOTHERAPY DEVICES AND METHODS COMPRISING SUBSTITUTED CARBAZOLE COMPOUNDS NITTO DENKO CORPORATION (JP) 2012-01-19 US disclosed
US-20120016449-A1 PHOTOTHERAPY DEVICES AND METHODS COMPRISING SUBSTITUTED CARBAZOLE COMPOUNDS NITTO DENKO CORPORATION (JP) 2012-01-19 US disclosed
US-20120016449-A1 PHOTOTHERAPY DEVICES AND METHODS COMPRISING SUBSTITUTED CARBAZOLE COMPOUNDS NITTO DENKO CORPORATION (JP) 2012-01-19 US disclosed
US-20110315964-A1 NOVEL POLYMERIZABLE MONOMER, AND MATERIAL FOR ORGANIC DEVICE, HOLE INJECTION/TRANSPORT MATERIAL, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT AND ORGANIC ELECTROLUMINESCENT ELEMENT EACH COMPRISING POLYMER (POLYMERIC COMPOUND) OF THE POLYMERIZABLE MONOMER IDEMITSU LOSAN CO., LTD. 2011-12-29 US disclosed
WO-2011034967-A1 COMPOUNDS FOR ORGANIC LIGHT EMITTING DIODE EMISSIVE LAYERS NITTO DENKO CORPORATION (JP) 2011-03-24 WO disclosed
WO-2011034967-A1 COMPOUNDS FOR ORGANIC LIGHT EMITTING DIODE EMISSIVE LAYERS NITTO DENKO CORPORATION (JP) 2011-03-24 WO disclosed
US-20110062386-A1 COMPOUNDS FOR ORGANIC LIGHT EMITTING DIODE EMISSIVE LAYERS NITTO DENKO CORPORATION (JP) 2011-03-17 US disclosed
US-20110062386-A1 COMPOUNDS FOR ORGANIC LIGHT EMITTING DIODE EMISSIVE LAYERS NITTO DENKO CORPORATION (JP) 2011-03-17 US disclosed
US-20110062386-A1 COMPOUNDS FOR ORGANIC LIGHT EMITTING DIODE EMISSIVE LAYERS NITTO DENKO CORPORATION (JP) 2011-03-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150987-A1 COMPOSITION FOR ORGANIC ELECTRONIC DEVICES SLCO2B1, SLCO2A1, SLCO1B3 KDM4E 3745/4885L3MBTL1 3258/4885ATM 4632/4885
US-20120016449-A1 PHOTOTHERAPY DEVICES AND METHODS COMPRISING SUBSTITUTED CARBAZOLE COMPOUNDS TYR, PPOX, CRY1 KDM4E 2150/4885L3MBTL1 241/4885ATM 3004/4885
US-20110062386-A1 COMPOUNDS FOR ORGANIC LIGHT EMITTING DIODE EMISSIVE LAYERS ALOX12, ALOX15B, ALOX15 KDM4E 3582/4885L3MBTL1 1844/4885ATM 4315/4885
US-20200231578-A1 COMPOSITION FOR ORGANIC ELECTRONIC DEVICES SLCO2B1, SLCO2A1, SLCO1B3 KDM4E 3745/4885L3MBTL1 3258/4885ATM 4632/4885
US-20110315964-A1 NOVEL POLYMERIZABLE MONOMER, AND MATERIAL FOR ORGANIC DEVICE, HOLE INJECTION/TRANSPORT MATERIAL, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT AND ORGANIC ELECTROLUMINESCENT ELEMENT EACH COMPRISING POLYMER (POLYMERIC COMPOUND) OF THE POLYMERIZABLE MONOMER EPB41, USE1, EPB41L2 KDM4E 3468/4885L3MBTL1 2592/4885ATM 3285/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.